CELESTICA INC (CLS) Fundamental Analysis & Valuation

NYSE:CLS • CA15101Q2071

Current stock price

281.68 USD
+24.41 (+9.49%)
At close:
283.8 USD
+2.12 (+0.75%)
After Hours:

This CLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CLS Profitability Analysis

1.1 Basic Checks

  • In the past year CLS was profitable.
  • In the past year CLS had a positive cash flow from operations.
  • In the past 5 years CLS has always been profitable.
  • In the past 5 years CLS always reported a positive cash flow from operatings.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS's Return On Assets of 11.54% is amongst the best of the industry. CLS outperforms 93.55% of its industry peers.
  • CLS's Return On Equity of 37.56% is amongst the best of the industry. CLS outperforms 97.58% of its industry peers.
  • CLS has a Return On Invested Capital of 24.36%. This is amongst the best in the industry. CLS outperforms 100.00% of its industry peers.
  • CLS had an Average Return On Invested Capital over the past 3 years of 17.88%. This is significantly above the industry average of 8.33%.
  • The 3 year average ROIC (17.88%) for CLS is below the current ROIC(24.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • CLS's Profit Margin of 6.72% is fine compared to the rest of the industry. CLS outperforms 73.39% of its industry peers.
  • CLS's Profit Margin has improved in the last couple of years.
  • CLS has a Operating Margin of 7.80%. This is in the better half of the industry: CLS outperforms 72.58% of its industry peers.
  • CLS's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 12.06%, CLS is not doing good in the industry: 75.81% of the companies in the same industry are doing better.
  • CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CLS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
  • The number of shares outstanding for CLS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CLS has less shares outstanding
  • Compared to 1 year ago, CLS has an improved debt to assets ratio.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 6.08 indicates that CLS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CLS (6.08) is better than 79.03% of its industry peers.
  • CLS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • CLS has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. CLS outperforms 81.45% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that CLS is not too dependend on debt financing.
  • CLS has a Debt to Equity ratio of 0.34. This is in the lower half of the industry: CLS underperforms 64.52% of its industry peers.
  • Although CLS's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z 6.08
ROIC/WACC2.84
WACC8.58%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • CLS has a Current Ratio of 1.44. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CLS (1.44) is worse than 77.42% of its industry peers.
  • A Quick Ratio of 0.88 indicates that CLS may have some problems paying its short term obligations.
  • The Quick ratio of CLS (0.88) is worse than 84.68% of its industry peers.
  • The current and quick ratio evaluation for CLS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. CLS Growth Analysis

3.1 Past

  • CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.59%, which is quite impressive.
  • The Earnings Per Share has been growing by 43.67% on average over the past years. This is a very strong growth
  • The Revenue has grown by 28.46% in the past year. This is a very strong growth!
  • The Revenue has been growing by 16.61% on average over the past years. This is quite good.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • CLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.90% yearly.
  • The Revenue is expected to grow by 36.42% on average over the next years. This is a very strong growth
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. CLS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 46.48 indicates a quite expensive valuation of CLS.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLS is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 25.35, CLS is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 31.29, the valuation of CLS can be described as expensive.
  • CLS's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.61. CLS is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 46.48
Fwd PE 31.29
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • CLS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • CLS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 70.63
EV/EBITDA 26.05
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • CLS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of CLS may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 40.90% in the coming years.
PEG (NY)0.96
PEG (5Y)1.06
EPS Next 2Y46.28%
EPS Next 3Y40.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLS Dividend Analysis

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLS Fundamentals: All Metrics, Ratios and Statistics

CELESTICA INC

NYSE:CLS (3/31/2026, 8:26:42 PM)

After market: 283.8 +2.12 (+0.75%)

281.68

+24.41 (+9.49%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners72.98%
Inst Owner Change3.67%
Ins Owners0.79%
Ins Owner Change50.64%
Market Cap32.37B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.18
Price Target270.25 (-4.06%)
Short Float %3.21%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)0%
PT rev (3m)8.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.01%
EPS NY rev (1m)7.19%
EPS NY rev (3m)7.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.29%
Valuation
Industry RankSector Rank
PE 46.48
Fwd PE 31.29
P/S 2.61
P/FCF 70.63
P/OCF 49.08
P/B 14.6
P/tB 20.02
EV/EBITDA 26.05
EPS(TTM)6.06
EY2.15%
EPS(NY)9
Fwd EY3.2%
FCF(TTM)3.99
FCFY1.42%
OCF(TTM)5.74
OCFY2.04%
SpS107.83
BVpS19.29
TBVpS14.07
PEG (NY)0.96
PEG (5Y)1.06
Graham Number51.28
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
ROICexc(3y)21.34%
ROICexc(5y)16.25%
ROICexgc(3y)28.33%
ROICexgc(5y)22.11%
ROCE(3y)21.66%
ROCE(5y)16.53%
ROICexgc growth 3Y42.82%
ROICexgc growth 5Y38.52%
ROICexc growth 3Y48.19%
ROICexc growth 5Y40.13%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z 6.08
F-Score7
WACC8.58%
ROIC/WACC2.84
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year74.41%
EBIT Next 3Y58.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 7 / 10 to CLS.


What is the valuation status of CELESTICA INC (CLS) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELESTICA INC (CLS). This can be considered as Fairly Valued.


Can you provide the profitability details for CELESTICA INC?

CELESTICA INC (CLS) has a profitability rating of 8 / 10.


What is the expected EPS growth for CELESTICA INC (CLS) stock?

The Earnings per Share (EPS) of CELESTICA INC (CLS) is expected to grow by 48.55% in the next year.